{"database":"JPOST Repository","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Mzxml":["https://storage.jpostdb.org/JPST003841/files/DMC-Ala_6h_3.mzXML","https://storage.jpostdb.org/JPST003841/files/Cisplatin_2h_3.mzXML","https://storage.jpostdb.org/JPST003841/files/DMC-Ala_2h_3.mzXML","https://storage.jpostdb.org/JPST003841/files/Cisplatin_6h_3.mzXML","https://storage.jpostdb.org/JPST003841/files/Cisplatin_6h_2.mzXML","https://storage.jpostdb.org/JPST003841/files/Cisplatin_8h_1.mzXML","https://storage.jpostdb.org/JPST003841/files/DMC-Ala_8h_1.mzXML","https://storage.jpostdb.org/JPST003841/files/DMC-Ala_6h_2.mzXML","https://storage.jpostdb.org/JPST003841/files/DMSO_2h_1.mzXML","https://storage.jpostdb.org/JPST003841/files/DMSO_2h_2.mzXML","https://storage.jpostdb.org/JPST003841/files/DMC-Ala_2h_1.mzXML","https://storage.jpostdb.org/JPST003841/files/DMC-Ala_8h_3.mzXML","https://storage.jpostdb.org/JPST003841/files/DMC-Ala_6h_1.mzXML","https://storage.jpostdb.org/JPST003841/files/Cisplatin_8h_2.mzXML","https://storage.jpostdb.org/JPST003841/files/Cisplatin_2h_1.mzXML","https://storage.jpostdb.org/JPST003841/files/DMC-Ala_2h_2.mzXML","https://storage.jpostdb.org/JPST003841/files/DMC-Ala_8h_2.mzXML","https://storage.jpostdb.org/JPST003841/files/Cisplatin_2h_2.mzXML","https://storage.jpostdb.org/JPST003841/files/Cisplatin_8h_3.mzXML","https://storage.jpostdb.org/JPST003841/files/Cisplatin_6h_1.mzXML"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Proteomics"],"submitter":["Padchanee Sangthong"],"species":["Cellular Organisms"],"full_dataset_link":["https://repository.jpostdb.org/entry/JPST003841"],"submitter_affiliation":["BIOTEC"],"sample_protocol":[""],"repository":["jPOST"],"data_protocol":[""],"additional_accession":[]},"is_claimable":false,"name":"4′-O-(L-Alanylated) DMC as a EEbB3 Inhibitor Drug with Therapeutic Potential against Cervical Cancer: Insights into SiHa Squamous Cervical Cancer Cell Line","description":"Cervical cancer is the most common gynecological malignancy and is primarily associated with infection by human papillomavirus (HPV). Phytochemicals have emerged as promising alternative agents for cancer therapy. ","dates":{"publication":"Sun May 31 00:00:00 GMT+01:00 2026"},"accession":"PXD064466","cross_references":{"TAXONOMY":["131567"]}}